What Oxitone Medical does

Oxitone Medical Ltd. is an Israel-based medtech and digital health company developing a wrist-worn, FDA-cleared continuous patient monitoring platform. Its proprietary FlexSense technology places multi-parameter medical biosensors against the ulna bone, capturing SpO2, pulse rate, heart rate variability, respiratory rate, skin temperature, sleep, activity, and (in the 2000M generation) cuffless blood pressure. Two hardware generations anchor the product line: the Oxitone 1000M, the first FDA 510(k)-cleared wrist-sensor pulse oximeter (mass production launched January 2020), and the next-generation Oxitone 2000M, which adds continuous cuffless blood pressure measurement. Device data is routed via Bluetooth Low Energy or API into the Oxitone cloud platform, which provides physician dashboards, clinical reports, smart notifications, and an AI-enabled Medical Intelligence module for baseline anomaly detection, exacerbation prediction, and automated patient follow-up. The company's stated AI follow-up capability carries a U.S. regulatory caveat, which is a meaningful commercialization constraint in its primary market.

The business model combines medical device hardware sales (Oxitone 1000M and 2000M) with a recurring SaaS platform subscription (Oxitone Integrated SaaS / Clinical Portal) and professional services for implementation and clinical support. Pricing is not publicly disclosed and is quote-based through an enterprise "Request a Demo" funnel, consistent with a consultative field-sales motion. Oxitone targets three primary customer segments: healthcare providers (hospitals, health systems, nursing homes, physician practices managing high-risk chronic patients), payers (insurance companies seeking risk stratification and care management), and pharma/CRO organizations (clinical trial endpoint data and post-market surveillance). Distribution is direct enterprise sales supported by US (Hartford, CT) and Israel (Kfar Saba) offices, complemented by OEM/embedded integrations with healthcare-IT vendors such as Ascom (Digistat Wearables). Named reference customers are limited (Baptist Health in Louisville and the Ascom channel), and total disclosed funding across five rounds since 2010 is approximately $10.5 million, with the most recent raise a $1 million round in September 2020 led by Telcom Ventures. Leadership comprises CEO and co-founder Ofer Harpak, founder and executive chairman Dr. Leon Eisen, and COO/CFO Morris Azulay.

Name

Oxitone Medical

Legal name

Oxitone Medical Ltd.

Website

https://oxitone.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Oxitone Medical is an Israel-based medtech company that builds FDA-cleared wrist-worn biosensors (Oxitone 1000M and 2000M) and a cloud SaaS platform for continuous remote monitoring of high-risk chronic patients, serving healthcare providers, payers, and pharma/CRO customers.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

• Remote patient monitoring
• Medical biosensors
• Continuous vital signs
• AI healthcare analytics
• Wearable medical devices

Headquarters

HQ city

Kfar Saba

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Hardware Sales: Sale of FDA-cleared wrist-worn medical monitoring devices including Oxitone 1000M (first FDA-cleared wrist-sensor pulse oximeter) and Oxitone 2000M (cuffless blood pressure monitor). Devices are sold to healthcare providers, payers, and directly to patients.
2. SaaS/Cloud Platform Subscription: Subscription-based access to Oxitone cloud platform with integrated SaaS portal, clinical dashboards, data analytics, and medical intelligence tools. Includes API integration capabilities for enterprise customers.
3. Professional Services: Implementation and support services for healthcare providers, payers, and pharma/CRO organizations including training, integration, and ongoing clinical support.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Oxitone Medical designs and sells FDA-cleared wrist-worn medical biosensors (Oxitone 1000M and Oxitone 2000M) that continuously monitor blood oxygen, pulse rate, HRV, respiratory rate, blood pressure, and other vital signs. The devices are paired with a cloud-based SaaS platform that provides AI-driven predictive analytics, physician dashboards, and API/Bluetooth integration for healthcare providers, payers, and pharmaceutical/CRO customers.

Product overview

Oxitone Medical offers a unified Digital Continuous Care platform centered on wearable medical devices and cloud-based analytics. The core product portfolio includes two generations of FDA-cleared wrist-worn biosensors (Oxitone 1000M and Oxitone 2000M) that provide continuous monitoring of blood oxygen, pulse rate, HRV, respiratory rate, and other vital signs. These devices are complemented by the Oxitone Integrated SaaS Platform, which provides the cloud infrastructure, physician portals, dashboards, and data analytics tools for comprehensive patient monitoring. The Oxitone Medical Intelligence module adds AI-powered predictive analytics and automated patient follow-up capabilities. Together, these products form an end-to-end continuous remote patient monitoring (CRPM) solution designed for high-risk chronic patients, enabling real-time health data collection, AI-powered anomaly detection and prediction, and automated clinical workflows for providers, payers, and pharma/CRO organizations.

Differentiator

Problem solved

Functional benefit

Products and services

• Oxitone 2000M Next-generation FDA-cleared wrist-worn medical monitor providing continuous cuffless blood pressure measurement (systolic and diastolic), cardiac monitoring (pulse rate, HRV, cardiac output), respiratory monitoring (SpO2, respiratory rate), and wellness tracking (skin temperature, sleep, activity, dehydration). Sold to healthcare providers, payers, and pharma/CRO customers for continuous patient monitoring.
• Oxitone 1000M First FDA 510(k)-cleared wrist-sensor pulse oximetry monitor for continuous patient monitoring. The wrist-worn device continuously monitors pulse rate, Heart Rate Variability (HRV), blood oxygen saturation (SpO2), respiratory rate, skin temperature, sleep patterns, and activity. Features FlexSense technology that embraces the ulna bone for medical-grade accuracy and enhanced comfort.
• Oxitone Integrated SaaS Platform Full end-to-end patient monitoring software platform including physician web portal and dashboards, secured cloud infrastructure, data analytics tools, clinical reports, API integration tools, and on-demand data delivery. Supports multi-parameter patient monitoring across providers, payers, and pharma/CRO clients with Bluetooth Low Energy device integration.

Quantifiable outcome

• Zero COVID-19 patient readmissions at Baptist Health using continuous monitoring
• +4 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability4 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Ascom UMScoreTechnology or Integration · 5 July 2020Ascom UMS selected Oxitone Medical for continuous monitoring of COVID-19 patients through integration of the Oxitone 1000M into the Digistat® Wearables solution. This integration enriches information collected from wearable devices, enabling significant enhancement of patient monitoring capabilities.
• MedtronicminorOthersListed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.
• Siemens HealthineersminorOthersListed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.
• MC10minorOthersListed as a key player in the North America AI Diagnostics Market alongside Oxitone Medical. Both companies leverage AI to enhance diagnostic accuracy and efficiency across hospitals, research laboratories, and contract research organizations.
• StartUp HealthminorGTM or Marketing PartnerStartUp Health featured Oxitone 1000M in their Tech Product Watch series, highlighting how Oxitone's wrist-worn continuous pulse oximeter brings the hospital into the home and replaces bulky fingertip devices.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Masimo: Masimo is the dominant global manufacturer of pulse oximetry and patient-monitoring technologies. It directly competes with Oxitone in clinical-grade SpO2 and continuous vital-signs monitoring, especially in the hospital and post-acute settings where Oxitone markets its wrist-sensor oximeter.
• iRhythm Technologies: iRhythm offers the Zio wearable for continuous cardiac arrhythmia monitoring with cloud-based analytics. It is comparable to Oxitone as a wearable, FDA-cleared, AI-driven continuous-monitoring device company selling into the same provider/payer ecosystem for chronic cardiac patients.
• Nonin Medical: Nonin is a long-established pulse oximetry and capnography device manufacturer. It is comparable as a direct competitor in SpO2 and vital-signs monitoring hardware, particularly for fingertip and wearable form factors used in clinical and remote-patient-monitoring applications.
• Vivify Health: Vivify Health provides a remote patient monitoring SaaS platform with connected device integration for chronic disease management. It is comparable as a SaaS-based RPM platform sold to providers and payers, addressing many of the same chronic-care and post-acute use cases Oxitone targets.
• Current Health: Current Health (Best Buy Health) offers an FDA-cleared continuous vital-signs monitoring platform combining a wearable device with AI-powered analytics and provider dashboards. It directly mirrors Oxitone's hardware-plus-SaaS model targeting high-risk chronic and post-acute patient populations.

Emerging players

• Biobeat: Biobeat is an Israeli wearable RPM company offering cuffless BP and multi-parameter vital-signs monitoring patches and wrist devices. It is a closely comparable emerging competitor with similar cuffless-BP positioning, overlapping geographies (Israel origin), and overlapping customer segments.

Broad incumbents

• Preventice Solutions (Boston Scientific): Preventice, acquired by Boston Scientific, offers BodyGuardian wearable cardiac RPM with cloud analytics. It is comparable as a continuously-worn, FDA-cleared vital-signs monitor sold into the same provider remote-monitoring workflows Oxitone addresses, now backed by a major medtech incumbent.
• Medtronic: Medtronic is a broad medical-device incumbent offering continuous cardiac and patient monitoring solutions (LINQ, VitalConnect partnerships, Patient Monitoring). It overlaps with Oxitone across hospital and remote cardiac/vital-signs monitoring and was named alongside Oxitone in AI diagnostics market coverage.
• GE Healthcare: GE Healthcare is a global incumbent in hospital patient monitoring (CARESCAPE) and AI-enabled diagnostics. It overlaps Oxitone on continuous vital-signs monitoring for in-hospital and ambulatory patients and was named alongside Oxitone in AI diagnostics market landscape reports.
• Omron Healthcare: Omron is the dominant consumer and clinical blood pressure monitor brand globally with expanding connected/wireless BP devices. It is comparable to Oxitone's Oxitone 2000M cuffless BP offering as a competitor in the ambulatory BP monitoring market with strong brand and distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/2384676
• Xx.com/OxitoneMedical
• Facebookfacebook.com/Oxitone

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds5 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxitone Medical